BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21295334)

  • 61. Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas.
    Gurkan D; Ceren Akin A; Sahin H; Aytac Tohma Y; Sahin EA; Gunakan E; Iflazoglu N; Nihan Haberal A; Ayhan A
    J Obstet Gynaecol; 2020 May; 40(4):551-557. PubMed ID: 31482736
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status.
    Gallotta V; Bruno M; Conte C; Giudice MT; Davià F; Moro F; Zannoni GF; Fagotti A; De Bonis M; Capoluongo E; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2020 Jul; 46(7):1327-1333. PubMed ID: 32085925
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
    Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
    Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
    Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ovarian carcinomatosis: how the radiologist can help plan the surgical approach.
    Nougaret S; Addley HC; Colombo PE; Fujii S; Al Sharif SS; Tirumani SH; Jardon K; Sala E; Reinhold C
    Radiographics; 2012 Oct; 32(6):1775-800; discussion 1800-3. PubMed ID: 23065169
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
    Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
    Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
    Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
    Kim HS; Bristow RE; Chang SJ
    Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
    Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatic resection for metachronous metastases from ovarian carcinoma.
    Merideth MA; Cliby WA; Keeney GL; Lesnick TG; Nagorney DM; Podratz KC
    Gynecol Oncol; 2003 Apr; 89(1):16-21. PubMed ID: 12694649
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.
    Matsuo K; Eno ML; Ahn EH; Shahzad MM; Im DD; Rosenshein NB; Sood AK
    Am J Clin Oncol; 2011 Oct; 34(5):488-93. PubMed ID: 20921883
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
    Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
    Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intestinal surgery in treatment of advanced ovarian cancer--review of our experience.
    Stefanović A; Jeremić K; Kadija S; Milincić N; Mircić A; Petković S; Zizić V
    Eur J Gynaecol Oncol; 2011; 32(4):419-22. PubMed ID: 21941966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.
    Fagotti A; Vizzielli G; Fanfani F; Costantini B; Ferrandina G; Gallotta V; Gueli Alletti S; Tortorella L; Scambia G
    Gynecol Oncol; 2013 Nov; 131(2):341-6. PubMed ID: 23938372
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer.
    Sawyer BT; LaFargue CJ; Bristow RE
    Gynecol Oncol; 2016 Aug; 142(2):378. PubMed ID: 27264212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
    Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
    Yavuzcan A; Baloglu A; Cetinkaya B
    Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.